{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:14Z","timestamp":1787010134021,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) with peritoneal metastasis (PM) is rare. There has been no standard treatment for this severe disease, and the conventional palliative therapy could only reach an overall survival of 6 to 14 months<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 38-year-old male with a chief complain of \u201cabdominal distension and diagnosis of HCCPM for 3 months\u201d, was suffering from severe diarrhea and moderate anemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>Diagnostic laparoscopic exploration with biopsy and the following pathology confirmed the diagnosis of HCC with PM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient was treated with cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) followed by 6 cycles of intraperitoneal chemotherapy and 6 cycles of intravenous chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Till January 15, 2019, the patient has progression-free survival for over 22 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>CRS plus HIPEC combined adjuvant intraperitoneal and intravenous chemotherapy may improve progression-free survival for some HCC with PM patients and should be considered as an option for such patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000014628","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T15:42:32Z","timestamp":1551368552000},"page":"e14628","source":"Crossref","is-referenced-by-count":5,"title":["Long-term progression-free survival of hepatocellular carcinoma with synchronous diffuse peritoneal metastasis treated by CRS+HIPEC"],"prefix":"10.1097","volume":"98","author":[{"given":"Zhong-He","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Lin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Bao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.5301\/tj.5000197","article-title":"Hepatocellular carcinoma with peritoneal metastasis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy","volume":"101","author":"Bhagwandin","year":"2015","journal-title":"Tumori"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.ejso.2018.05.021","article-title":"Is there an oncological interest in the combination of CRS\/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study","volume":"44","author":"Mehta","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.suronc.2011.01.005","article-title":"Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma","volume":"21","author":"Chua","year":"2012","journal-title":"Surg Oncol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1440-1746.2009.05848.x","article-title":"Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis","volume":"24","author":"Lin","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"734","DOI":"10.47102\/annals-acadmedsg.V39N9p734","article-title":"Hepatocellular carcinoma peritoneal metastases: report of three cases and collective review of the literature","volume":"39","author":"Ding","year":"2010","journal-title":"Ann Acad Med Singapore"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.surg.2012.03.031","article-title":"Resection of peritoneal metastases in patients with hepatocellular carcinoma","volume":"153","author":"Hashimoto","year":"2013","journal-title":"Surgery"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/jso.23739","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma","volume":"110","author":"Tabrizian","year":"2014","journal-title":"J Surg Oncol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jso.24340","article-title":"Extrahepatic metastasectomy for hepatocellular carcinoma: predictors of long-term survival","volume":"114","author":"Berger","year":"2016","journal-title":"J Surg Oncol"},{"key":"R10-20230914","first-page":"20","article-title":"Hepatocellular carcinoma peritoneal metastasis: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"1","author":"Spiliotis","year":"2017","journal-title":"Gulf J Oncolog"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201902220-00077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T12:18:21Z","timestamp":1694693901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201902220-00077"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014628","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}